Evidence map›Paper›PMID 42067667›Full record

ArticleNature biotechnology2026

TxPert: using multiple knowledge graphs for prediction of transcriptomic perturbation effects.

Frederik Wenkel, Wilson Tu, Cassandra Masschelein, Hamed Shirzad, Liam Hodgson, Ihab Bendidi, Cian Eastwood, Shawn T Whitfield, Craig Russell, Yassir El Mesbahi and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Frederik Wenkel *Valence Labs, Montréal, Quebec, Canada. frederik@valencelabs.com.ORCID http://orcid.org/0000-0002-3832-8402
Wilson Tu *Valence Labs, Montréal, Quebec, Canada.
Cassandra MasscheleinValence Labs, Montréal, Quebec, Canada.ORCID http://orcid.org/0009-0001-7216-6320
Hamed ShirzadValence Labs, Montréal, Quebec, Canada.
Liam HodgsonValence Labs, Montréal, Quebec, Canada.
Ihab BendidiValence Labs, Montréal, Quebec, Canada.
Cian EastwoodValence Labs, Montréal, Quebec, Canada.
Shawn T WhitfieldValence Labs, Montréal, Quebec, Canada.ORCID http://orcid.org/0000-0002-6309-2550
Craig RussellValence Labs, Montréal, Quebec, Canada.
Yassir El MesbahiValence Labs, Montréal, Quebec, Canada.
Jiarui DingComputer Science, University of British Columbia, Vancouver, British Columbia, Canada.ORCID http://orcid.org/0000-0003-3670-7764
Marta M FayRecursion, Salt Lake City, UT, USA.
Berton EarnshawValence Labs, Montréal, Quebec, Canada.ORCID http://orcid.org/0000-0002-9728-2408
Emmanuel NoutahiValence Labs, Montréal, Quebec, Canada.ORCID http://orcid.org/0000-0001-5216-9703
Alisandra K DentonValence Labs, Montréal, Quebec, Canada. ali@valencelabs.com.ORCID http://orcid.org/0000-0002-1132-0224

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurately predicting cellular responses to genetic perturbations is essential for understanding disease mechanisms and designing effective therapies. Yet, exhaustively exploring the space of possible perturbations (for example, multigene perturbations or across tissues and cell types) is prohibitively expensive, motivating methods that can generalize to unseen conditions. We present TxPert, a latent-transfer-based deep learning method that uses multiple knowledge graphs of gene (product)-gene (product) relationships to predict transcriptomic perturbation effects. Different knowledge graphs encode complementary information and we show that a combination of graphs derived from biological databases and high-throughput perturbation screens yields the best performance. For predictions of single unseen perturbations, TxPert approaches the performance of split-half experimental reproducibility. For double unseen perturbations and single perturbations in a different cell line, its predictions increase Person Δ for unseen single perturbations by 8-25% over existing methods.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.